Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-18

Clinical Trial Update: U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne [NA]

View source ↗

Summary

This document summarizes a completed open-label 12-week trial evaluating the Acne System containing benzoyl peroxide 2.5% and salicylic acid 0.5% for acne vulga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzoyl Peroxide 2.5% (benzoyl peroxide)
  • Salicylic Acid 0.5% (salicylic acid)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | NA | Status: COMPLETED | Results posted: 2017-04-18